Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Eradicating N. Meningitidis Carriage
NCT06618534Phase 2Completed
- Sponsor
- Emory University
- Start
- Nov 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azithromycin in meningococcal infection, sponsored by Emory University. Primary endpoint: Eradication of N. meningitidis carriage at 21 days. Started Nov 2024; status: completed.
02
Drugs
azithromycin
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT06618534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618534.